magazine archive


magazine archive

Smaller Companies

Air Partner achieves £6.4m profit one year earlier than expected

Thursday 25 Jan 2018

It looks like analysts will be forced to upgrade their earnings forecasts for Air Partner ( AIR ) after the company revealed an impressive trading update on 18 January. It said underlying pre-tax profit for the year to 31 January 2018 would be at least £6.4m. That compares with current market...

Overlooked retailer Quiz has the answers

Thursday 25 Jan 2018

Fast fashion womenswear brand Quiz ( QUIZ:AIM ) proved a Christmas retail winner and is a growth stock that should excite small cap investors. Pocket the value-for-money occasion wear-to-dressy casual wear specialist at 150p, where there is 46% upside towards Panmure Gordon’s 219p price target...

Carr’s is on the comeback trail

Thursday 18 Jan 2018

Recovery investors should bag shares in agriculture-to-engineering combine Carr’s ( CARR ) . The company’s first quarter update (9 Jan) highlighted improving performance in both the agriculture and engineering divisions which was ‘significantly ahead’ of last year. Investec Securities has a ‘buy’...

TechFinancials play on cryptocurrencies

Thursday 18 Jan 2018

Tiny derivatives trading platform provider and technology developer TechFinancials ( TECH:AIM ) is exciting speculators thanks to its stake in a blockchain-based diamond exchange. The company bought a 2% stake in Cedex in December for $200,000, but it has an option to buy up to another 90% of Cedex...

Why President Energy’s shares can keep rising

Thursday 18 Jan 2018

Latin American oil and gas play President Energy ( PPC:AIM ) is generating more cash than expected from its recently acquired Puesto Flores field in Argentina. A combination of higher oil prices and a low-risk approach to expanding Argentinian production makes President’s shares look an attractive...

Silence Therapeutics benefits from innovative gene tech

Thursday 18 Jan 2018

Biotech business Silence Therapeutics ( SLN:AIM ) could benefit from a rapid growth in ribonucleic acid (RNA) therapies between 2017 and 2022. The market is expected to be worth over $7bn at the end of this period according to Peel Hunt. Silence does not use gene-editing CRISPR technology, its...

Redhall going upmarket

Thursday 18 Jan 2018

Engineering firm Redhall ( RHL:AIM ) is getting a better quality and quantum of orders, building on an encouraging full year performance in 2017. The delayed £8m contract on the Hinkley Point nuclear plant is now expected to complete in 2018. The company raised £9.5m through a placing in June 2017...

Small caps with more than 5% dividend yields

Thursday 11 Jan 2018

You may be surprised at the number of smaller companies which pay dividends. Many investors may assume that dividends are only the domain of mid and large caps, yet we demonstrate in this article that you can find plenty of opportunities further down the market cap spectrum. We’ve analysed the...

WANdisco offers bigger carrot

Thursday 07 Dec 2017

Data replication technology developer WANdisco ( WAND:AIM ) has raised $22m from investors to meet strong customer demand, far more than the $10m originally targeted. Getting investors to participate may have been difficult with the shares close to recent highs of 881.5p, representing a 345% share...

Eve's sleep disruption

Thursday 07 Dec 2017

Premium memory foam mattress business Eve Sleep (EVE:AIM ) has shrugged off faltering UK consumer confidence to report (29 Nov) continued positive sales momentum in the second half of 2017. Current marketing initiatives are proving successful at driving sales and raising brand awareness, says the...

Pages